뉴스벤징가
AbbVie’s Costly Apogee Acquisition Has Long-Term Upside: Analyst
· 발표
기사 요약
AbbVie will acquire Apogee Therapeutics for $10.9 billion, with analyst citing long-term immunology growth despite near-term dilution.
기사 원문에서 발췌했어요.뉴스 본문을 불러오고 있어요.
AbbVie will acquire Apogee Therapeutics for $10.9 billion, with analyst citing long-term immunology growth despite near-term dilution.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…